Tectonic Therapeutic, Inc. SEC filings TECX
Tectonic Therapeutic, Inc. has 582 filings in SEC EDGAR's recent list, going back to Aug 3, 2016. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (acquisition or sale of assets). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 POS | Filing | Mar 9, 2026 | — |
| S-8 | Employee stock plan registration | Feb 27, 2026 | — |
| 424B3 | Prospectus | Jul 15, 2025 | — |
| POS AM | Filing | Jul 7, 2025 | — |
| POS AM | Filing | Jul 7, 2025 | — |
| S-3 | Shelf registration | Jul 7, 2025 | — |
| 424B5 | Prospectus supplement | Jun 11, 2025 | — |
| 424B5 | Prospectus supplement | Jun 11, 2025 | — |
| 424B5 | Prospectus supplement | May 19, 2025 | — |
| 424B5 | Prospectus supplement | May 19, 2025 | — |
| 424B3 | Prospectus | May 8, 2025 | — |
| 424B3 | Prospectus | May 8, 2025 | — |
| POS AM | Filing | Mar 27, 2025 | — |
| S-1 | Registration statement | Mar 26, 2025 | — |
| S-8 | Employee stock plan registration | Mar 20, 2025 | — |
| 424B5 | Prospectus supplement | Feb 12, 2025 | — |
| 424B5 | Prospectus supplement | Feb 12, 2025 | — |
| 424B3 | Prospectus | Feb 12, 2025 | — |
| S-8 POS | Filing | Aug 27, 2024 | — |
| S-8 | Employee stock plan registration | Aug 21, 2024 | — |
| 424B3 | Prospectus | Aug 14, 2024 | — |
| 424B5 | Prospectus supplement | Jul 31, 2024 | — |
| 424B3 | Prospectus | Jul 30, 2024 | — |
| S-1 | Registration statement | Jul 19, 2024 | — |
| 424B3 | Prospectus | May 3, 2024 | — |
| S-4/A | Filing | Apr 29, 2024 | — |
| S-4/A | Filing | Apr 15, 2024 | — |
| S-4/A | Filing | Mar 26, 2024 | — |
| S-4 | Registration for a merger or exchange | Feb 14, 2024 | — |
| S-8 | Employee stock plan registration | Mar 23, 2023 | — |
| S-3 | Shelf registration | Nov 8, 2022 | — |
| S-8 | Employee stock plan registration | Aug 9, 2022 | — |
| S-8 | Employee stock plan registration | Mar 17, 2022 | — |
| S-8 | Employee stock plan registration | Mar 18, 2021 | — |
| 424B5 | Prospectus supplement | Nov 20, 2020 | — |
| 424B5 | Prospectus supplement | Nov 19, 2020 | — |
| S-8 | Employee stock plan registration | Aug 6, 2020 | — |
| S-8 | Employee stock plan registration | Mar 16, 2020 | — |
| 424B5 | Prospectus supplement | Feb 13, 2020 | — |
| 424B5 | Prospectus supplement | Feb 12, 2020 | — |
| S-8 | Employee stock plan registration | Dec 20, 2019 | — |
| S-3 | Shelf registration | Dec 20, 2019 | — |
| 424B5 | Prospectus supplement | Dec 20, 2019 | — |
| S-8 | Employee stock plan registration | Nov 12, 2019 | — |
| 424B5 | Prospectus supplement | Jul 17, 2019 | — |
| 424B5 | Prospectus supplement | Jul 16, 2019 | — |
| S-3 | Shelf registration | Jul 1, 2019 | — |
| S-8 | Employee stock plan registration | Mar 25, 2019 | — |
| S-8 | Employee stock plan registration | Mar 25, 2019 | — |
| S-8 | Employee stock plan registration | Jun 21, 2018 | — |
| 424B4 | Prospectus | Jun 21, 2018 | — |
| S-1MEF | Filing | Jun 20, 2018 | — |
| S-1/A | Amended registration statement | Jun 18, 2018 | — |
| S-1/A | Amended registration statement | Jun 11, 2018 | — |
| S-1/A | Amended registration statement | Jun 1, 2018 | — |
| S-1 | Registration statement | May 25, 2018 | — |
Showing 56 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- TECX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NY
- Headquarters
- Watertown, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1681087
- Former names
- AvroBio, Inc. (until Jun 18, 2024); AVROBIO, Inc. (until Jun 18, 2024)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.